Mark Kokoris

Biography

 20+ years of experience working on the cutting edge of biotechnology. Mr. Kokoris’s passion is to conceive and develop innovative and transforming technologies. He co-founded Stratos Genomics in 2007 in order to pursue a vision of creating a next generation DNA sequencing technology that would enable broader use in healthcare. In pursuit of this goal, Mr. Kokoris co-invented the SBX™ technology that same year. In 2003, he founded the biotechnology consulting firm BioCaptus, LLC where his experience in the fields of high throughput genomics, molecular diagnostics, protein engineering, and microfluidics was utilized by clients to develop a broad range of technologies and applications. Prior to forming BioCaptus, Mr. Kokoris was the Director of Services and Technology for QIAGEN Genomics, Inc. He was responsible for QGI’s entire genomic services offering as well as all aspects of technology and process development. As one of the founding members of Rapigene, he played a key role in the development of the Cleavable Mass Spec Tag (CMST) technology and in establishing the company’s high-throughput genotyping facility. Mr. Kokoris, who is an inventor or co-inventor on 7 issued US patents, holds a B.S. in Biochemistry from the University of California, Davis.

Research Interest

 Oncology